Thailand
Thailand
Explore linked clinical trials.204 results · Page 1 of 9
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Amphoe Mueang | Amphoe Mueang | Thailand | 1 |
| Amphoe Mueang | Amphoe Mueang | Thailand | 1 |
| Ban Phaeo | Ban Phaeo | Thailand | 2 |
| Ban Phaeo | Ban Phaeo | Thailand | 1 |
| Bang Kapi | Bang Kapi | Thailand | 1 |
| Bang Khae | Bang Khae | Thailand | 1 |
| Bang Kho Laem | Bang Kho Laem | Thailand | 1 |
| Bang Lamung | Bang Lamung | Thailand | 2 |
| Bang Phlat | Bang Phlat | Thailand | 1 |
| Bang Phlat | Bang Phlat | Thailand | 1 |
| Bangkok | Bangkok | Thailand | 3 |
| Bangkok | Bangkok | Thailand | 386 |
| Bangkok | Bangkok | Thailand | 86 |
| Bangkok | Bangkok | Thailand | 2 |
| Bangkok | Bangkok | Thailand | 11 |
| Bangkok | Bangkok | Thailand | 2 |
| Bangkok | Bangkok | Thailand | 1 |
| Bangkok | Bangkok | Thailand | 2 |
| Bangkok | Bangkok | Thailand | 1 |
| Bangkok | Bangkok | Thailand | 2 |
| Bangkok | Bangkok | Thailand | 3 |
| Bangkok | Bangkok | Thailand | 1 |
| Bangkok | Bangkok | Thailand | 1 |
| Bangkok | Bangkok | Thailand | 1 |
| Bangkok | Bangkok | Thailand | 13 |
747 results · Page 1 of 30
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003) | Small Cell Lung Cancer Extensive Stage | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07227597 | |
| Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-10-09 | NCT07100080 | |
| Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency | Bone Diseases, Developmental, Bone Diseases, Endocrine, Dwarfism, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, hypopituitarism, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder | Recruiting | Phase 3 | 2026-10-09 | NCT06948214 | |
| A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007) | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 3 | 2026-10-09 | NCT06878261 | |
| A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Recruiting | Phase 3 | 2026-10-09 | NCT06858579 | |
| Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-10-09 | NCT06757634 | |
| A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer. | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 3 | 2026-10-09 | NCT05984277 | |
| Southeast Asia Dose Optimization of Tafenoquine | Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium vivax malaria, Recurrence, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 4 | 2026-10-09 | NCT04704999 | |
| Dabrafenib and/or Trametinib Rollover Study | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, epithelial neoplasm, glioma, lung disorder, lung neoplasm, malignant glioma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, neuroepithelial neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm | Recruiting | Phase 4 | 2026-10-09 | NCT03340506 | |
| Common Femoral Vein-to-Artery Diameter Ratio for Detection of Elevated Left Ventricular End-Diastolic Pressure: Diagnostic Accuracy Study | Diagnosis of Elevated LVEDP Using Ultrasound of the Common Femoral Vein to Common Femoral Artery Diameter Ratio | Recruiting | Not stated | 2026-10-08 | NCT07866859 | |
| Cardiovascular Risk Assessment and Coronary Calcium Score in Thai MASLD Patients | Digestive System Diseases, cardiovascular disorder, liver disorder | Recruiting | Not stated | 2026-10-08 | NCT07865936 | |
| The Effect of Catheter Size on the Efficacy of Ultralow-flow Extracorporeal Carbon Dioxide Removal System in Acute Respiratory Distress Syndrome | Lung Injury, acute lung injury, lung disorder, respiratory system disorder | Not yet recruiting | Not applicable | 2026-10-08 | NCT07858136 | |
| Shrimp Sensitization and Allergy Among Patients With Edible Insect Allergy | Edible Insect Allergy; Shrimp Allergy; Shrimp Sensitization | Recruiting | Not applicable | 2026-10-08 | NCT07857187 | |
| Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-10-08 | NCT07680790 | |
| Development and Validation of the Paediatric Scale for Quality of Recovery in the Post-Anaesthesia Care Unit | Postoperative Recovery in Children | Recruiting | Not stated | 2026-10-08 | NCT07610915 | |
| Greater Occipital Nerve Block for Migraine With Medication Overuse Headache | Analgesic Overuse Headache, Headache Disorders, Secondary, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Recruiting | Not applicable | 2026-10-08 | NCT07568496 | |
| Changes in Hemodynamic Response Following Transcranial Electrical Stimulation in Sroke Individuals | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-10-08 | NCT07433972 | |
| Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients | Confusion, Critical Illness, Disease Attributes, Neurobehavioral Manifestations, Neurologic Manifestations, Parasomnias, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorder, sleep disorder, sleep-wake disorder | Recruiting | Phase 4 | 2026-10-08 | NCT07407400 | |
| A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, chronic renal failure syndrome, heart disorder, kidney disorder, kidney failure, nervous system disorder, stroke disorder, urinary system disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07241390 | |
| A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07060807 | |
| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 3 | 2026-10-08 | NCT06925737 | |
| Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, bacterial infectious disease, chronic kidney disease, chronic renal failure syndrome, gram-positive bacterial infections, kidney disorder, kidney failure, mycobacterial infectious disease, tuberculosis, urinary system disorder | Active, not recruiting | Not stated | 2026-10-08 | NCT06700876 | |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions | Hemic and Lymphatic Diseases, anemia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 3 | 2026-10-08 | NCT06499285 | |
| Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation. | Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-10-08 | NCT05445843 | |
| Guideline Oriented Approach To Lipid Lowering In Asia-Pacific | Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, acute coronary syndrome, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, heart disorder, hyperlipidemia, metabolic disease, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-10-08 | NCT05325034 |